Refine by
Immunotherapy Software
7 software items found
by:Lunit Inc. based inSeoul, SOUTH KOREA
Predicting immunotherapy outcome with AI analysis; Finding more responders to cancer treatment; Tissue Data is huge and complex; Complex is what AI does ...
by:NEC OncoImmunity AS based inOslo, NORWAY
NEC OncoImmunity AS has developed an AI engine for its clinical projects, known as the NEC Immune Profiler, that predicts from next generation sequencing data true neoantigens for personalized cancer immunotherapy and cancer immunotherapy ...
by:Cypre, Inc. based inSan Francisco, CALIFORNIA (USA)
Cypre’s 3D Tumor Models combine the tumor, stromal and immune compartments in a high throughput format to screen targeted drugs and immunotherapy. In 2021, we partnered with Charles River to offer our 3D Tumor Models for drug discovery and preclinical screening services. Cypre Panels rapidly screen small molecules, biologics and cell therapy in 3D hydrogel in vitro tumor ...
by:Lunit Inc. based inSeoul, SOUTH KOREA
Quantifying PD-L1 positivity with AI analysis; Finding more PD-L1 positive patients; Counting every PD-L1 positive tumor cell; Complex is what AI does ...
by:Certara based inPrinceton, NEW JERSEY (USA)
Biological medicines (“biologics” or “large molecule drugs”) now account for 30% of new drug approvals and up to 50% of the pharmaceutical industry’s pipeline. Biologics differ from small molecules because they are much larger, have slower absorption rates, confined distribution, and different elimination. They are designed for a specific target, typically found on ...
Manufactured by:OncoDNA S.A. based inGosselies, BELGIUM
Order OncoDNA's solutions, browse your patients' history and receive your personalised report on treatment recommendations. When you join OncoSHARE, you become a member of an active network gathering together more than 13,000 patients and oncologists. Regardless of whether the information concerns patient health or payment, we take every precaution to ensure your security. OncoSHARE is used by ...
by:Immunai based inNew York, NEW YORK (USA)
Immunai’s end-to-end single-cell platform enables high resolution profiling of the immune system at industrial scale, generating biological insights that accelerate R&D and power novel ...